PLEASANTON, Calif., Oct. 25 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in products to treat cardiovascular disease, today announced that it will report its operating results for the third quarter of fiscal 2007 on Thursday, November 1.
The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 8:30 a.m., Pacific Daylight Time (11:30 a.m., Eastern Daylight Time), Thursday, November 1, hosted by Gary F. Burbach, president and chief executive officer, and David Smith, executive vice president and chief financial officer.
The teleconference can be accessed by calling (913) 312-0946, passcode 4366700. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will also be available on the Internet at http://phx.corporate-ir.net/playerlink.zhtml?c=95989&s=wm&e=1671294 or at http://www.thoratec.com.
A replay of the conference call will be available through Thursday, November 15, via http://www.thoratec.com or by telephone at (719) 457-0820, passcode 4366700.
Thoratec Corporation is a world leader in therapies to address advanced
stage heart failure. The company's product lines include the Thoratec(R)
VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular
Assist System) with more than 11,000 devices implanted in patients
suffering from heart failure. Additionally, its International Technidyne
Corporation (ITC) division supplies blood testing and skin incision
|SOURCE Thoratec Corporation|
Copyright©2007 PR Newswire.
All rights reserved